DOI: http://dx.doi.org/10.18203/issn.2455-4529.IntJResDermatol20203750

A cross sectional study to investigate the prevalence of metabolic syndrome in clinically diagnosed patients of psoriasis vulgaris in South Gujarat

Pankti Manit Gundavda, Priyanka Chandrakant Patil, Dipak D. Umrigar

Abstract


Background: Psoriasis is a common, chronic, inflammatory keratinization disorder of the skin. It can be triggered by many environmental as well as genetic factors.  The metabolic syndrome (syndrome X, insulin resistance syndrome) consists of a constellation of metabolic abnormalities that confer increased risk of cardiovascular disease (CVD) and diabetes mellitus (DM). Often coexistence is noticed between psoriasis and metabolic syndrome.

Methods: A cross-sectional study was conducted in the Government medical college and new civil hospital, Surat. A total of 115 clinically diagnosed cases of psoriasis vulgaris and similar age and sex matched controls visiting dermatology out patients’ department of new civil hospital, Surat were selected for the study.

Results: Prevalence of metabolic syndrome is significantly higher in psoriatic patients after the age of 40 years, and it directly correlates to psoriasis duration. No association observed with gender, percentage of body surface area involved and smoking, but in patients of 18-40 years with metabolic syndrome had significantly higher percentage of body surface area involved as compared to >40 years age group.

Patients with metabolic syndrome had mean disease duration of 5.52±5.83 years and BMI was 27.48±4.36.

Conclusions: Higher prevalence of metabolic syndrome in patients with psoriasis could play a relevant role in accelerating atherosclerosis. All patients with psoriasis should be encouraged to aggressively correct their modifiable cardiovascular risk factors.


Keywords


Psoriasis, Metabolic syndrome, Atherosclerosis, Complications, Diabetes

Full Text:

PDF

References


Schon MP, Boehncke WH. Psoriasis. N Engl J Med. 2005; 352:1899-912.

Gelfand JM, Weinstein R, Porter SB, Neimann AL, Berlin JA, Margolis DJ. Prevelance and treatment of psoriasis in the United Kingdom: A population-based study. Arch Dermatol. 2005;141:1537-41.

Henseler T, Christophers E. Psoriasis of early and late onset: characterisation of two types of psoriasis vulgaris. J Am Acad Dermatol. 1985;13:450-6.

Nisa N, Qazi MA. Prevalence of metabolic syndrome in patients with psoriasis. Indian J Dermatol Venereol Leprol. 2010;76:662-5.

Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: A joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120:1640-5.

Cohen AD, Sherf M, Vidavsky L, Vardy DA, Shapiro J, Meyerovitch J. Association between psoriasis and the metabolic syndrome. Dermatol. 2008; 216:152-5.

Rodríguez-Zúñiga MJ, García-Perdomo HA. Systematic review and meta-analysis of the association between psoriasis and metabolic syndrome. Journal of the American Academy of Dermatology. 2017;77(4):657-66.

Reaven GM. Banting lecture 1988: Role of insulin resistance in human disease. Diabetes. 1988;37: 1595-607.

Armstrong AW, Harskamp CT, Armstrong EJ. Psoriasis and metabolic syndrome: a systematic review and meta-analysis of observational studies. J Am Acad Dermatol. 2013;68:654-62.

Weinberg JM. Lifestyle issues and psoriasis. Cutis. 2006; 78:160.

Gisondi P, Tessari G, Conti A, Piaserico S, Schianchi S, Peserico A, et al. Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based case-control study. Br J Dermatol. 2007;157:68-73.

Luigi N, Chatenoud L, Belloni A, Peserico A, Balato N, Virgili AR, et al. Medical history, Drug exposure and risk of psoriasis: results from an Italian case control study. Clinicaal and laboratory investigations. Dermatol. 2008;216:125-32.

Zhang C, Zhu K, Zheng H, Cui Y, Zhou F, Chen Y, et al. The effect of overweight and obesity on psoriasis patients in Chinese Han population: a hospital-based study. JEADV. 2011;25(1):87-91.

Al-Mutairi N, Al-Farag S, Al-Mutairi A, Al-Shiltawy M. Comorbidities associated with psoriasis: an experience from the Middle East. J. Dermatol. 2010;37(2):146-55.

Sommer DM, Jenisch S, Suchan M, et al. Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis. Arch Dermatol Res. 2006;298:321-8.

Kremers HM, McEvoy MT, Dann FJ, Gabriel SE. Heart disease in psoriasis. J Am Acad Dermatol. 2007;57:347-54.

Naldi L, Parazzini F, Brevi A, Peserico A, Veller Fornasa C, Grosso G, et al. Family history, smoking habits, alcohol consumption and risk of psoriasis. Br J Dermatol. 1992;127:212-7.

Crist LA, Champagne CM, Corsino L, Lien LF, Zhang G, Young DR. Influence of change in aerobic fitness and weight on prevalence of metabolic syndrome. Prev Chronic Dis. 2012;9:E68.

Zindancý I, Albayrak O, Kavala M, Kocaturk E, Can B, Sudogan S, et al. Prevalence of metabolic synd-rome in patients with psoriasis. Scientific World Journal. 2012;2012;312463.

Kim GW, Park HJ, Kim HS, Kim SH, Ko HC, Kim BS, et al. Analysis of cardiovascular risk factors and metabolic syndrome in Korean patients with psoriasis. Ann Dermatol. 2012;24:11-5.

Dreiher J, Weitzman D, Davidovici B, Shapiro J, Cohen AD. Psoriasis and dyslipidaemia: A population-based study. Acta Derm Venereol. 2008;88:561-5.

Shapiro J, Cohen AD, Weitzman D, Tal R, David M. Psoriasis and cardiovascular risk factors: A case-control study on inpatients comparing psoriasis to dermatitis. J Am Acad Dermatol. 2012;66:252-8.

Kothiwala SK, Khanna N, Tandon N, Naik N, Sharma VK, Sharma S, et al. Prevalence of metabolic syndrome and cardiovascular changes in patients with chronic plaque psoriasis and their correlation with disease severity: A hospital-based cross-sectional study. Indian J Dermatol Venereol Leprol. 2016;82:510-8.

Pereira RR, Amladi ST, Varthakavi PK. A study of the prevalence of diabetes, insulin resistance, lipid abnormalities, and cardiovascular risk factors in patients with chronic plaque psoriasis. Indian J Dermatol. 2011;56:520-6.

Madanagobalane S, Anandan S. Prevalence of metabolic syndrome in South Indian patients with psoriasis vulgaris and the relation between disease severity and metabolic syndrome: A hospital-based case-control study. Indian J Dermatol. 2012;57:353-7.